Both in Pharmaceuticals
Liquidia vs Parabilis Medicines
Over the past year LQDA returned −36.8% and PBLS returned −20.7%; their daily moves had a correlation of 0.00.
LQDA −36.8% PBLS −20.7%Growth of $1, one year, split-adjusted
| Metric | LQDA | PBLS |
|---|---|---|
| Price | $42.20 | $29.25 |
| Market cap | $3.78B | $3.61B |
| Today | +0.84% | +7.34% |
| 1 month | +52.7% | −0.9% |
| 6 months | +5.2% | — |
| Year to date | +22.4% | — |
| 1 year | +73.2% | — |
| Revenue growth (YoY) | +1842.7% | — |
| Gross margin | 93.3% | 100.0% |
| Net margin | 43.5% | −45239.9% |
| P/E (TTM) | 27.3× | — |
| Price / sales | 8.4× | — |
| Net cash | $108.1M | $1.11B |
| Dividend yield | — | — |
| Volatility (60d) | 189.7% | — |
| Short % of float | 26.2% | 9.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).